Evecxia Therapeutics Receives Notice Of Allowance For A U.S. Patent Covering Its Lead Drug Candidate EVX‑101

– Allowed broad claims cover the EVX-101 structure, composition, and function – The patent adds to a growing portfolio of issued and pending patents RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Evecxia Therapeutics, Inc., the leader in serotonin synthesis amplification to treat brain disorders, today announced that the U.S. Patent and Trademark Office has allowed U.S. patent application … [Read more…]

Castle Biosciences Collaborates with IMPACT Melanoma to Provide Free Sunscreen to Cyclists Participating in the Bike MS: Texas MS 150 2023 Cycling Event

Thirteen sunscreen dispensers, positioned at rest and lunch stops, will supply sunscreen to the more than 5,200 riders to protect their skin from sunburn during the two-day event FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has teamed up with … [Read more…]

Colgate Announces 1st Quarter 2023 Results

NEW YORK–(BUSINESS WIRE)–Colgate-Palmolive Company (NYSE:CL): Net sales increased 8.5%; Organic sales* increased 10.0% with growth in every division and in all four categories GAAP EPS declined 32% to $0.45; Base Business EPS* declined 1% to $0.73 GAAP Gross profit margin and Base Business Gross profit margin* both decreased 160 basis points to 56.9%, including a … [Read more…]

Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2023

MILWAUKEE–(BUSINESS WIRE)–Sensient Technologies Corporation (NYSE: SXT) reported consolidated revenue of $369.0 million in this year’s first quarter compared to $355.5 million in last year’s first quarter. Reported operating income in the first quarter of 2023 was $50.8 million compared to $52.8 million in the first quarter of 2022. Reported diluted earnings per share was 80 … [Read more…]

ImmunoGen Reports Recent Progress and First Quarter 2023 Financial Results

Strong Adoption of ELAHERE; Net Sales of $29.5 Million in First Full Quarter of Launch Top-Line Results from Confirmatory MIRASOL Trial Anticipated in Early May; Expected to Support Full Approval of ELAHERE in the US and Expansion into Europe Announced Non-Dilutive Financing for Up to $175 Million to Strengthen Balance Sheet and Support Company’s Growth … [Read more…]

Ossium Health Awarded $3.46M in Funding from the California Institute of Regenerative Medicine (CIRM) to Advance the Development of OSSM-007 for the Treatment of Steroid-Refractory Acute Graft versus Host Disease (GVHD)

SAN FRANCISCO–(BUSINESS WIRE)–Ossium Health, Inc. announced today that the California Institute of Regenerative Medicine (CIRM) has awarded the company a $3.46M Clinical Stage Research Program (CLIN1) grant to support the continued clinical development of OSSM-007, Ossium’s interferon-gamma primed mesenchymal stem cell product, for the treatment of steroid-refractory acute graft versus host disease (GVHD). This funding … [Read more…]

Global Pregnancy Test Kits Market 2023 – 2028: Rising Rate of Unintended Pregnancies Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pregnancy Test Kits Market – Global Outlook & Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global pregnancy test kits market is expected to grow at a CAGR of 5.08% during 2022 to 2028. With the rising research and development and advancement in pregnancy testing kits, vendors offer innovative kits that … [Read more…]

Metabolomics Global Market Report 2023: Sector to Reach $4.7 Billion by 2028 at an 11.85% CAGR – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global metabolomics market size reached US$ 2.4 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.85% during 2022-2028. … [Read more…]

Handwashing During ‘Normal Times’ Can Reduce Burden of Respiratory Disease – Reckitt Global Hygiene Institute

New research published in The Lancet reinforces the idea that handwashing outside of pandemic times is vital in order to reduce the burden of common colds and flu in low- and middle-income countries. PARSIPPANY, N.J.–(BUSINESS WIRE)–Analysis of studies involving 160,000 people across three continents reinforces message that handwashing is not just for pandemics. Handwashing with … [Read more…]

PureTech Announces Annual Results for Year Ended December 31, 2022

Strong capital base with PureTech level cash, cash equivalents and short-term investments of $339.5 million1 and consolidated cash, cash equivalents and short-term investments of $350.1 million,2 as of December 31, 2022. Rapid advancement of PureTech’s Wholly Owned Pipeline, with four clinical stage therapeutic candidates, including LYT-100 (ongoing registration-enabling trial in IPF), LYT-300 (Phase 2 ready … [Read more…]